MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Dentate Deep Brain Stimulation for Cerebellar Ataxia: Long Term Outcomes

C. França, J. Diniz, I. Paraguay, D. de Andrade, V. Silva, R. Galhardoni, M. Teixeira, E. Barbosa, R. Cury (São Paulo, Brazil)

Meeting: 2024 International Congress

Abstract Number: 1310

Keywords: Ataxia: Treatment, Deep brain stimulation (DBS)

Category: Ataxia

Objective: To evaluate long-term results of Deep Brain Stimulation (DBS) targeting the dentate nucleus (DN) in patients with cerebellar ataxia

Background: Cerebellar ataxia remains a neurological symptom orphan of treatment interventions, despite being prevalent and incapacitating. In a previous study, we evaluated safety and clinical outcomes of patients with cerebellar ataxia and DN DBS, comparing ON and OFF-stimulation in a double-blind manner [1]

Method: This is a randomized, prospective, double-blind, cross-over clinical trial registered at clinicaltrials.gov (protocol NCT03341416) and conducted in University of São Paulo to evaluate long-term outcomes of dentate nucleus DBS in ataxic patients. Primary outcomes are changes in the Scale for the Assessment and Rating of Ataxia (SARA) and in the Fahn Tolosa Marin Tremor Rating Scale (FTM) comparing ON and OFF stimulation. Patients arrived at the hospital with DBS ON, and the device was immediately turned OFF. After 30 minutes, patients were randomized to have DBS turned ON or remain OFF. After additional 30 minutes, patients were evaluated with clinical scales mentioned above, and switched groups, waiting for 30 minutes more. Finally, patients were again evaluated using clinical scales, and dismissed from the study protocol with DBS ON (Figure)

Results: Six patients from our original cohort were included. ON and OFF clinical data (Table) failed to demonstrate an acute beneficial effect of DN-DBS.

Conclusion: ON and OFF evaluations of DN-DBS with a 30-minutes interval failed to show clinical benefit. It is possible that DN DBS effects, similar to those of Globus Pallidus Internus in dystonic patients, need more time to appear after turning DBS ON, and more time to disappear after DBS OFF, due to a network adaptive effect.

Table: Results

Table: Results

Figure: Study design

Figure: Study design

References: 1. Cury RG, França C, Duarte KP, Paraguay I, Diniz JM, Cunha P, et al. Safety and Outcomes of Dentate Nucleus Deep Brain Stimulation for Cerebellar Ataxia. Cerebellum. 2021 Sep 4;21(5):861–5

To cite this abstract in AMA style:

C. França, J. Diniz, I. Paraguay, D. de Andrade, V. Silva, R. Galhardoni, M. Teixeira, E. Barbosa, R. Cury. Dentate Deep Brain Stimulation for Cerebellar Ataxia: Long Term Outcomes [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/dentate-deep-brain-stimulation-for-cerebellar-ataxia-long-term-outcomes/. Accessed May 17, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/dentate-deep-brain-stimulation-for-cerebellar-ataxia-long-term-outcomes/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley